Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
evaluate the Efficacy of high flow nasal oxygen as a weaning strategy in mechanically ventilated patients with respiratory failure.
Acute respiratory failure is a main cause of IMV and admission to intensive care unit (ICU){1}.
The day of extubation is a critical time during an intensive care unit (ICU) stay because in case of postextubation failure {2},which reach to 25 - 40% from extubated patient associated with VAP and barotrauma, mortality rate and hospital stay will increase , we use Adjuvant oxygen therapy to prevent these undesirable event like COT ,NIV and High-flow nasal cannula (HFNC) which can be used as an initial weaning strategy from IMVdue to its physiologic benefits [3-4].
HFNC devices supply between 30 and 60 L/min of a controlled mixture of actively warmed (32-37 °C) and humidified (up to 100% relative humidity) oxygen and air through modified nasal prongs. producing {5-6-7}:
Mechanisms:
e) humidification may improve mucus drainage and reduce mucus retention, alleviating the associated atelectasis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High Flow Nasal Cannula | Device | use of high flow nasal cannula as a weaning mode from invasive mechanical ventilation to deliver oxygen |
| Measure | Description | Time Frame |
|---|---|---|
| Is patient outcome in terms of survival or death at discharge. | evaluate the Efficacy of high flow nasal oxygen as a weaning strategy in mechanically ventilated patients with respiratory failure as regarding Hospitalization ,complications, oxygenation , reintubation rate, mortality rate. | through study completion average 7 days. |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of ICU stay through study completion average 7 days ,Adverse events. | evaluate efficacy of high flow nasal cannula on duration of hospital stay, complications rate. | through study completion average 7 days. |
Not provided
Inclusion Criteria:
1- All adult patients who were admitted to our ICU requiring endotracheal intubation (ETI), were eligible for the study.
Exclusion Criteria:
Not provided
Not provided
all patient in respiratory ICU who mechanically intubated will be enrolled in study by using high flow nasal oxygen as a weaning strategy.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Hamed Fr Qenawy, Bachelor | Contact | 01061812045 | hamedfarrag216@gmail.com | |
| Doaa Mo Magdy, Lecturer | Contact | 01006261010 | doaamagdy_2020@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Suzan Sl Sayed, Professor | Assiut University | Study Director |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26969671 | Background | Papazian L, Corley A, Hess D, Fraser JF, Frat JP, Guitton C, Jaber S, Maggiore SM, Nava S, Rello J, Ricard JD, Stephan F, Trisolini R, Azoulay E. Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med. 2016 Sep;42(9):1336-49. doi: 10.1007/s00134-016-4277-8. Epub 2016 Mar 11. | |
| 29558988 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Helviz Y, Einav S. A Systematic Review of the High-flow Nasal Cannula for Adult Patients. Crit Care. 2018 Mar 20;22(1):71. doi: 10.1186/s13054-018-1990-4. |
| 29144160 | Result | Drake MG. High-Flow Nasal Cannula Oxygen in Adults: An Evidence-based Assessment. Ann Am Thorac Soc. 2018 Feb;15(2):145-155. doi: 10.1513/AnnalsATS.201707-548FR. |